Clinical trial
A Randomized, Placebo Controlled Trial of Nitrous Oxide/Oxygen Plus Standard Care Versus Standard Care Alone During In-office Intradetrusor onabotulinumtoxinA (Botox) Injections
NCT07387315 is registered in ClinicalTrials.gov with TriHealth Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Randomized, Placebo Controlled Trial of Nitrous Oxide/Oxygen Plus Standard Care Versus Standard Care Alone During In-office Intradetrusor onabotulinumtoxinA (Botox) Injections
- Lead sponsor
- TriHealth Inc.
- Phase
- Phase 4
- Overall status
- Not yet recruiting
- Start date
- February 28, 2026
- Completion date
- December 31, 2026
- Enrollment
- 96 (estimated)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.
neurogenic bladder, overactive bladder, pain, pelvic floor disorders, urge incontinence, urinary bladder neurogenesis, urinary bladder, neurogenic, urinary bladder, overactive, urinary incontinence, urinary incontinence, urge